NCT06698471

Brief Summary

Despite the growing prevalence of mental health disorders in low- and middle-income countries, significant barriers to seeking and accessing mental health services persist. Within lower income populations, the prevalence of mental health disorders and barriers to addressing them are worsened by poverty. Self-Help Plus is a group-based stress management program delivered using a task-sharing model and designed to circumvent barriers to addressing mental health concerns. Cultural adaptations of Self-Help Plus have been implemented in several countries and are considered cost-effective. However, to date, Self-Help Plus has not been adapted for Senegalese populations. The study detailed in this manuscript aims to assess the feasibility and acceptability of Self-Help Plus in lower income populations in Senegal. The study is a pilot feasibility cluster-randomized control trial of Self-Help Plus in four Senegalese communities. Clusters of social protection program beneficiaries will be randomly selected to receive five sessions of Self-Help Plus. The intervention will be delivered in groups of up to 30 beneficiaries and co-facilitated by two community workers. A combination of quantitative and qualitative research methods will be used to assess the feasibility and acceptability of both the Self-Help Plus intervention and randomized control trial procedures. The study sample will include social protection program beneficiaries in the treatment and control groups, Self-Help Plus facilitators, project staff supporting the training of facilitators, and the intervention supervisor. The findings of this study will be used to inform the potential integration of Self-Help Plus and/or similar mental health interventions into the national social protection program in Senegal.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
748

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 22, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 21, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

February 24, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

May 2, 2025

Status Verified

March 1, 2025

Enrollment Period

7 months

First QC Date

October 22, 2024

Last Update Submit

April 29, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Engagement

    Of those who were offered the intervention, at least 25% attended one or more sessions.

    From enrollment to the end of treatment at 5 weeks

  • Retention

    At least 50% of the ever-attended beneficiaries attended at least any 4 intervention sessions

    From enrollment to the end of treatment at 5 weeks

  • Fidelity

    Fidelity to intervention elements at the level of 75% or greater according to the mean fidelity checklist for intervention elements across all sessions. Number of feasibility domains: n=15; higher is better, scored on 0-100%

    From enrollment to the end of treatment at 5 weeks

Secondary Outcomes (21)

  • General Health Questionnaire-12

    Prior to initiation of treatment

  • General Health Questionnaire-12

    2 months following initiation of treatment

  • General Health Questionnaire-12

    5 months following initiation of treatment

  • Patient Health Questionnaire-9

    Prior to initiation of treatment

  • Patient Health Questionnaire-9

    2 months following initiation of treatment

  • +16 more secondary outcomes

Other Outcomes (9)

  • Culture-specific measure of distress - Thinking too much

    Prior to initiation of treatment

  • Culture-specific measure of distress - Thinking too much

    2 months following initiation of treatment

  • Culture-specific measure of distress - Thinking too much

    5 months following initiation of treatment

  • +6 more other outcomes

Study Arms (2)

Treatment as usual

ACTIVE COMPARATOR

Treatment as usual from Health System in Senegal

Other: Referral to Health System

Relief from Stress via Social Protection in Senegal

EXPERIMENTAL

Training community workers in Self Help Plus intervention

Other: Community worker training

Interventions

Training community workers in Self Help Plus intervention, a 5 session self-help intervention based on Acceptance and Commitment Therapy

Relief from Stress via Social Protection in Senegal

Referral to Health System of Senegal

Treatment as usual

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Community Worker facilitators of the intervention:
  • Patients: Enrolled in the World Bank Social Protection Programme

You may not qualify if:

  • Community Worker facilitators of the intervention
  • Patients: Persons with a severe mental disorder or suicidality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre de Recherche Pour le Développement Economique et Social (CRDES)

Dakar, Senegal

Location

MeSH Terms

Conditions

Generalized Anxiety Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Officials

  • Syed S Wahid, Doctor of Public Health

    Georgetown University

    PRINCIPAL INVESTIGATOR
  • Anne Hilger, PhD

    World Bank

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors are masked to study arm
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Cluster randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2024

First Posted

November 21, 2024

Study Start

February 24, 2025

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

May 2, 2025

Record last verified: 2025-03

Locations